Top Markets
Coin of the day
Aelis Farma S.A. Aelis Farma S.A.

Aelis Farma S.A.

AELIS
Rankning i aktier #30387
Aelis Farma S.A., a French biotechnology company founded in 2013 and... Aelis Farma S.A., a French biotechnology company founded in 2013 and headquartered in Bordeaux, is dedicated to the discovery and development of treatments for brain-related illnesses. The firm's research pipeline primarily focuses on signaling-specific inhibitors that target CB1 receptors. Its leading investigational drug, AEF0117, is currently advancing through Phase 2b clinical trials, designed to alleviate the harmful impacts of excessive cannabis consumption. Furthermore, AEF0217, another key drug candidate, has successfully completed Phase 1 clinical trials, with the goal of addressing cognitive impairments linked to Down syndrome and other similar conditions.
Aktiekurs
$1.25
Senast synkroniserad: 2026-08-18
Marknadsvärde
$17.05M
Förändring (1 dag)
-1.50%
Förändring (1 år)
-22.24%
Land
FR
Handel Aelis Farma S.A. (AELIS)

Kategori

Historik för aktiesplit för Aelis Farma S.A. (AELIS)
Aktien Aelis Farma S.A. (symbol: AELIS) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 19, 2026.
En AELIS-aktie köpt före Aug 19, 2026 motsvarar nu 0 AELIS-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE